(Q84587303)

English

First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma

scientific article published on 18 July 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

based on heuristic

inferred from title

author name string

Liang Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Zhi-hui Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Xiao-qin Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Ya-jun Li

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Ke-feng Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yun-fei Xia

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Zhong-jun Xia

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

18 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

119

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

348-355

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Extranodal NK / T-cell lymphoma, nasal type: new staging system and treatment strategies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy--result of chemotherapy in NK/T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Supraadditive effect of 2',2'-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine modulation of alkylator therapy: a phase I trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine, etoposide, cisplatin, and dexamethasone in patients with refractory or relapsed non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

GEMOX-R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large-cell lymphoma: a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective apoptosis of natural killer-cell tumours by l-asparaginase.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 2 trial of "sandwich" L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

The anti-asparagines antibodies correlate with L-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27752

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.27752

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22811078%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84587303&oldid=1567992562"